Othman Ouenes on Why the Right Connections Matter for Cancer Startups – CancerX
Othman Ouenes/LinkedIn

Othman Ouenes on Why the Right Connections Matter for Cancer Startups – CancerX

CancerX shared on LinkedIn:

“Great technology doesn’t reach patients on its own. It takes the right people in the right room.

Meet Othman Ouenes, CEO of Fidari, one of the startups building inside the CancerX community, shares what his journey has looked like from the inside.

It’s a story we hear often from our founders: the breakthrough rarely comes from another workshop. It comes from a conversation with a clinician, a health-system innovation team, or a patient advocate they couldn’t have reached on their own.

That’s what the CancerX Accelerator offers:

  • A unique network of healthcare leaders across leading institutions
  • Feedback on your ideas, new projects, and warm introductions
  • An ecosystem with a track record of incubating successful companies

Join us in our mission to reduce cancer mortality by 50% by 2047.

Applications for the CancerX Accelerator Cohort 2027 close November 30.

Apply Here“

About CancerX

CancerX is a public-private partnership that brings together healthcare organizations, technology companies, researchers, startups, and government partners to advance digital innovation in cancer care. It was launched as part of the U.S. Cancer Moonshot initiative.

Key points:

  • Mission: Accelerate the development and adoption of digital solutions that improve cancer care.
  • Collaboration: Connect healthcare professionals, industry leaders, startups, investors, and government partners.
  • CancerX Accelerator: Support startups through mentorship, education, networking, and connections with healthcare organizations and investors.
  • Focus areas: Cancer screening, early diagnosis, treatment decisions, patient monitoring, and access to quality cancer care.
  • Goal: Help innovative solutions reach clinical practice and improve the experience and outcomes of people affected by cancer.

You may also be interested in: